Recidiva da papilomatose laríngea após tratamento cirúrgico
DOI:
https://doi.org/10.34631/sporl.573Palavras-chave:
Papiloma, Doenças da Laringe, Neoplasias, Papillomaviridae, Cirurgia, Quimioterapia AdjuvanteResumo
Objetivos: Analisar série de casos de papilomatose laríngea (PL) no Hospital Garcia de Orta. Rever técnicas cirúrgicas e terapêuticas adjuvantes atualmente existentes.
Métodos: Estudo retrospetivo dos doentes com PLentre 2009 e 2014. Analisados parâmetros epidemiológicos, clínicos e terapêuticos.
Resultados: Registaram-se 17 casos de PL, 88,2% do sexo masculino com média de idade 60,6±9,2 anos, 82% apresentavam hábitos tabágicos e 47% etanólicos. O sintoma de apresentação mais frequente foi a disfonia em 88% dos casos. A recidiva foi de 43,8%, com tempo médio de primeira recidiva de 13 meses, tendo sido a microcirurgia laríngea com remoção das lesões a frio a abordagem de eleição (75%). Em 2 casos, observou-se evolução para carcinoma pavimento-celular.
Conclusões: A PL apresenta comportamento recorrente. O tratamento cirúrgico continua a ser o pilar na abordagem, com uma nova tendência em relação ao microdebridor. É fundamental aumentar o tempo entre recidivas, considerando as terapêuticas adjuvantes disponíveis atualmente.
Referências
Avelino MAG, Zaiden TCDT, Gomes RO. Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis. Braz J Otorhinolaryngol. 2013;79(5):636–42.
Moura R, Fernandes J, Figueirinhas R, Costa C, et al. Papilomatose laríngea - casuísticado IPOFG-EPE do Porto. Revista Portuguesa de Otorrinolaringologia e Cirurgia Cérvico-Facial. 2010;48:15-20
Pontes P, Weckx LLM, Pignatari SSN, Fujita RR, et al. Aplicação local de cidofovir como tratamento adjuvante na papilomatose laríngea recorrente em crianças. Rev Assoc Med Bras. 2009;55(5):581–6.
Kendall K a. Current treatment for laryngeal papillomatosis. Curr Opin Otolaryngol Head Neck Surg. 2004;12:157–9.
Hočevar Boltežar I, Šereg Bahar M, Žargi M, Gale N, et al. Adjuvant therapy for laryngeal papillomatosis. Acta Dermatovenerologica Alpina, Pannonica Adriat. 2011;20:175–80.
Lindeberg H, Oster S, Oxlund I, Elbrønd O. Laryngeal papillomas: classification and course. Clin Otolaryngol Allied Sci. 1986;11:423–9.
Gutiérrez Castillo C, Monerris García E, Duran MD, Sancho Mestre M, et al. Papilomas y papilomatosis laríngea. Tratamiento con láser CO Nuestra experiencia en 15 años. Acta Otorrinolaringol Esp. 2010;61(6):422–7.
Derkay CS. Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg. 1995;121:1386–91.
Doyle DJ, Gianoli GJ, Espinola T, Miller RH. Recurrent respiratory papillomatosis: juvenile versus adult forms. Laryngoscope. 1994;104:523–7.
Ximenes Filho JA, Simoceli L, Imamura R, Tsuji DH, et al. Papilomatose laríngea recorrente: experiência de 10 anos. Rev Bras Otorrinolaringol. 2003;69(5):599–604.
Hasan S, Dutt SN, Kini U, Shariff S, et al. Laryngeal carcinoma expapilloma in a non-irradiated, non-smoking patient: a clinical record and review of the literature. The Journal of laryngology and otology. 1995. p. 762–6.
Armstrong LR, Derkay CS, Reeves WC. Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force. Arch Otolaryngol Head Neck Surg.
;125:743–8.
Batra PS, Hebert RL, Haines GK, Holinger LD. Recurrent respiratory papillomatosis with esophageal involvement. Int J Pediatr Otorhinolaryngol. 2001;58:233–8.
Hermann JS, Pontes P, Weckx LLM, Fujita R, et al. Laryngeal sequelae of recurrent respiratory papillomatosis surgery in children. Revista da Associação Médica Brasileira. 2012. p. 204–8.
Preuss SF, Klussmann JP, Jungehulsing M, Eckel HE, et al. Long-term results of surgical treatment for recurrent respiratory papillomatosis. Acta Otolaryngol [Internet]. 2007;127:1196–201. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17851940
Lehto L, Aaltonen LM, Rihkanen H. Longstanding recurrent laryngeal papillomatosis: Impact on voice quality. Eur Arch Oto-Rhino-Laryngology. 2007;264:777–82.
Harries ML, Juman S, Bailey CM. Recurrent respiratory papillomatosis in the larynx: re-emergence of clinical disease following surgery. International journal of pediatric torhinolaryngology. 1995. p. 259–62.
Aaltonen LM, Peltomaa J, Rihkanen H. Prognostic value of clinical findings in histologically verified adult-onset laryngeal papillomas. Eur Arch Oto-Rhino-Laryngology. 1997;254:219–22.
Doyle DJ, Henderson LA, LeJeune FE, Miller RH. Changes in human papillomavirus typing of recurrent respiratory papillomatosis progressing to malignant neoplasm. Archives of otolaryngology-head & neck surgery. 1994. p. 1273–6.
Kimberlin DW. Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis. Antivir Res. 2004;63:141–51.
Wemer RD, Lee JH, Hoffman HT, Robinson RA, et al. Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 2005;114:836–9.
Broekema FI, Dikkers FG. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol. 2008;265:871–9.
Zeitels SM, Barbu AM, Landau-Zemer T, Lopez-Guerra G, Burns JA, Friedman AD, et al. Local injection of bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocal folds: a prospective study. Ann Otol Rhinol Laryngol.
;120(10):627-34. PMID: 22097147
Pawlita M, Gissmann L. Recurrent respiratory papillomatosis: indication for HPV vaccination? Dtsch Med Wochenschr. 2009;134 Suppl 2:S100–2.
Mudry P, Vavrina M, Mazanek P, Machalova M, et al. Recurrent laryngeal papillomatosis: successful treatment with human papillomavirus vaccination. Archives of disease in childhood. 2011. p. 476–7.
